Summary: The aim of this study was the evaluation of the effects of Venoruton (HR) on the prevention and control of flight microangiopathy and edema in subjects with varicose veins flying for more than 7 hours. A group of 80 patients with varicose veins, edema, and initial skin alterations due to chronic venous hypertension were included. Measurements of skin laser Doppler (LDF) resting flux (RF), Po2 and rate of ankle swelling (RAS), were made before and after the flights (within 2 hours before the flights and within 2 hours after the flights). The length of the flights was between 7 and 9 hours; all seats were in coach class. The two groups (treatment and control) were comparable for age and sex distribution. The variation (decrease) in PO2 was significant in both groups. In subjects treated with HR the decrease in Po2 was smaller (p<0.05). The decrease in LDF-RF was Long-haul flights are associated with increasing edema, proportional to the hours spent in the aircraft, caused by increased capillary filtration, decreased external pressure in the cabin, and to other factors, such as restricted spaces and mobility, and altered fluid balance during flights (1-11). These physiological changes associated with edema have been defined as flight microangiopathy (FMA) in previous studies by our group. Recently long-haul flights have been associated with severe vascular problems including deep venous thrombosis and pulmonary embolism (8) (9) (10) (11) (12) (13) (14) (15) (16) . However during and after long flights, most normal individuals and subjects with varicose veins often complain of increasing swelling Address correspondence and reprint requests to G. Belcaro, MD, Via Vespucci 65, 65100 Pescara, Italy; e-mail: cardres@pe.abol.it. significant in both groups with a higher flux at the end of the flight in the treated subjects (p<0.05). The venoarteriolar response was decreased at the end of the flights. The decrease was less evident in the treatment group (p<0.05). The increase in RAS was significant in the control group while it was limited in the HR group. In conclusion, HR is useful for reducing the increased capillary filtration and in controlling edema in patients with chronic venous disease in long-haul flights. HR is effective to control flight microangiopathy associated with edema.
Long-haul flights are associated with increasing edema, proportional to the hours spent in the aircraft, caused by increased capillary filtration, decreased external pressure in the cabin, and to other factors, such as restricted spaces and mobility, and altered fluid balance during flights (1) (2) (3) (4) (5) (6) (7) (8) (9) (10) (11) . These physiological changes associated with edema have been defined as flight microangiopathy (FMA) in previous studies by our group. Recently long-haul flights have been associated with severe vascular problems including deep venous thrombosis and pulmonary embolism (8) (9) (10) (11) (12) (13) (14) (15) (16) . However during and after long flights, most normal individuals and subjects with varicose veins often complain of increasing swelling Address correspondence and reprint requests to G. Belcaro, MD, Via Vespucci 65, 65100 Pescara, Italy; e-mail: cardres@pe.abol.it. significant in both groups with a higher flux at the end of the flight in the treated subjects (p<0.05). The venoarteriolar response was decreased at the end of the flights. The decrease was less evident in the treatment group (p<0.05). The increase in RAS was significant in the control group while it was limited in the HR group. In conclusion, HR is useful for reducing the increased capillary filtration and in controlling edema in patients with chronic venous disease in long-haul flights. HR is effective to control flight microangiopathy associated with edema. Key Words: Microangiopathy-Flights-Airplanes-Edema-HR-0-(beta-hydroxyethyl)-rutosides-Paroven-Venoruton-Laser doppler flowmetry-Microcirculation-Venous diseases-Venoruton- Oxerutins. and edema that may vary from minor discomfort to severe problems associated with real signs of venous insufficiency. Venous problems are usually more evident and pronounced during and just after long flights and treatment and prophylaxis may be advisable to avoid signs, symptoms, and other medical problems. Elastic compression and low-molecular-weight heparin (one weightadjusted dose) have been successfully used to avoid thrombosis with positive results (16) (17) (18) (19) . However the problem of edema, the most frequent complaint after long-haul flights, has not been fully evaluated so far.
HR (Paroven, Venoruton; 0-(beta-hydroxyethyl) -rutosides) * has been used for many years to control venous disease associated with varicose veins and chronic venous insufficiency (20, 21) . HR has also been tested in long-haul flights to prevent edema (22) .
*Novartis Consumer Health
This study evaluated the effects of HR on the prevention and control of FMA and particularly on edema in subjects with varicose veins flying for more than 7 hours.
PATIENTS AND METHODS
After informed consent, a group of 80 patients with varicose veins, edema, and initial skin alterations due to chronic venous hypertension were included. Criteria for exclusion were recent (less than 24 months) venous thrombosis, recent surgery (within 6 months) or sclerotherapy, diabetic microangiopathy, bone/joint disease, alterations in mobility or invalidity, severe obesity, and any clinical condition requiring drug treatment (i.e., hypertension, cardiovascular and neoplastic disorders). Duplex scanning was performed according to previously published methods (23) (24) (25) .
No stockings or compression therapy were used for a week before the study flight and during the flight.
Treatment
One sachet of HR (1 g, twice daily) was used for 3 days before the flight (including the day of the flight). Subjects were included after informed consent and were randomized for treatment or equivalent placebo. The study was planned according to the European Unions' Clinical Trials Directive (37) .
Microcirculation
Measurements of skin laser Doppler (LDF) (26) (27) (28) , resting flux (RF), transcutaneous Po2, and rate of ankle swelling (RAS) as previously described (22, 26) , were made before and after the flights (within 4 hours before the flights and within 1 hour after the flights) in a room at controlled temperature. The length of the flights was between 9 hours and 9 hours and 30 minutes; all seats were in coach class. Subjects in flights lasting longer than 40 minutes over the expected flying time (9 hours) were excluded. Chronic venous insufficiency had been documented with color duplex scanning according to the methods described by our groups (25, 26) . Patients had varicose veins but no history of venous thrombosis and no ulcerations.
Ultrasound was performed at the moment of inclusion-to diagnose and define chronic venous insufficiency-and again just before (within 90 minutes) and just after (within 60 minutes) the end of the flight to exclude the presence of deep venous thrombosis.
Statistics
Pooled results from the two groups were statistically analyzed with non-parametric tests (analysis of variance and Mann-Whitney U-test).
RESULTS
Details of the studied subjects are shown in Table 1 and in Figures 1-3 VAR produces a marked increase in capillary filtration, clinically evident as edema. According to this study, this chain of events is partially but clearly controlled by HR treatment. Therefore the prophylactic administration of HR prevents a marked alteration in skin perfusion and effectively controls edema in subjects with venous hypertension flying for more than 7 hours.
flights. The effects are very clear in patients with varicose veins and venous hypertension but because significant, visible edema is observed even in most normal subjects (86%) after long flights (22) there is a potential application of HR even in normal subjects prone to edema, considering the absence of side effects, the limited cost, and its high efficacy. This is an independently funded study. There is no conflict of interest.
DISCUSSION
In venous insufficiency, incompetence of the superficial venous system is associated with an abnormally increased capillary filtration rate. Ankle edema can be effectively reduced and improved by elastic compression and by other measures. During flights the lower cabin pressure and reduced mobility cause edema almost in all subjects, even those without venous insufficiency (10) . For several reasons a large number of patients with varicose veins or chronic venous insufficiency travel on long-haul flights and physical and medical treatment to control edema could be an important option (27) (28) (29) (30) (31) (32) . Recent studies (33) (34) (35) mainly focus on thrombosis prevention without considering the problem of edema.
HR has been used effectively and without side effects to control edema and signs/symptoms associated with venous insufficiency and venous microangiopathy (20, 21) . The prophylactic use of medical treatment and specifically HR is effective in reducing and controlling edema and perfusional disorders due to long flights particularly in chronic venous hypertension and venous microangiopathy. According to these results, HR controls distal edema in venous hypertension by improving the venoarteriolar response and by controlling the capillary filtration rate. The decrease of RAS and edema is possibly dose-related (the higher dose producing a proportionally higher control).
There is some indication-however no defined information is available-that edema in longhaul flights may compress distal veins, possibly alter biochemical and blood factors, and initiate thrombosis.
These results are consistent with other studies showing the activity of HR on the microcirculation in patients with venous hypertension (20, 21) . In conclusion, HR is useful and effective in reducing the increased capillary filtration and in controlling edema and swelling in patients with venous hypertension (36), in long-haul
